- Recent Funding
- Investors
- Advent Life Sciences
Advent Life Sciences portfolio
Advent Life Sciences has 6 portfolio companies on record at Recent Funding.
About this page
It is a venture capital firm based in London, GB, founded in 2006. It led 3 of the 4 rounds it joined. Its most recent investment on record is Glycomine's $115M Series B+ round in May 2025, which it led, alongside RiverVest, Novo Holdings, Abingworth and 6 others. By category, its portfolio leans toward Health and bio (6) and Manufacturing and industrial (1). It has co-invested with CTI Life Sciences Fund, Sanofi Ventures and Abingworth, most often CTI Life Sciences Fund (2 rounds).
About Advent Life Sciences
What Advent Life Sciences invests in
- Health and bio · 6 · 100%
- Manufacturing and industrial · 1 · 17%
- Cybersecurity · 1 · 17%
Advent Life Sciences recent investments
| Company | Round | Date | Alongside |
|---|---|---|---|
| Series B+ · $115M · lead | RiverVest, Novo Holdings, Abingworth +6 | ||
| Series B+ · $58.72M · lead | Gilde Healthcare (lead), Earlybird VC (lead) | ||
| Series B+ · $80M · lead | Emerson Collective, SoftBank Vision Fund, Global Ventures +7 | ||
| Seed · $13.17M | Novateur Ventures, Fonds de solidarité FTQ, Cambridge Innovation Capital +2 |
How Advent Life Sciences invests
Advent Life Sciences portfolio companies
GGlycomine$115MSeries B+ · May 2025
AArgá Medtech$58.72MSeries B+ · Feb 2024
PProximie$80MSeries B+ · Jun 2022
EEpitopea$13.17MSeed · May 2022
FF2Gbacker
TT-Therapeuticsbacker
| Company | Round with Advent Life Sciences | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $115M · lead | $195M | May 9, 2025 Series B+ |
Health and bio |
Series B+ · $58.72M · lead | $58.72M | Feb 27, 2024 Series B+ |
Health and bio |
Series B+ · $80M · lead | $118M | Sep 18, 2024 Series B+ |
Health and bio |
Seed · $13.17M | $44.17M | Oct 24, 2024 Series A |
Health and bio |
backer | $100M | Sep 12, 2024 Series B+ |
Health and bio |
backer | $283M | Nov 5, 2026 Series B+ |
Most frequent co-investors
CCTI Life Sciences Fund2 shared rounds · last May 9, 2025
SSanofi Ventures1 shared round · last May 9, 2025
AAbingworth1 shared round · last May 9, 2025
NNovo Holdings1 shared round · last May 9, 2025
SSanderling Ventures1 shared round · last May 9, 2025
CChiesi Ventures1 shared round · last May 9, 2025
RRiverVest1 shared round · last May 9, 2025
AAsahi Kasei Corporate Venture Capital1 shared round · last May 9, 2025
RRemiges Ventures1 shared round · last May 9, 2025
GGilde Healthcare1 shared round · last Feb 27, 2024
EEarlybird VC1 shared round · last Feb 27, 2024
MMubadala Capital Ventures1 shared round · last Jun 1, 2022
Similar investors
AAdage Capital Management6 companies · 4 deals in 12 mo
SSymBiosis6 companies · 4 deals in 12 mo
44BIO Capital6 companies · 3 deals in 12 mo
HHBM Healthcare Investments6 companies · 3 deals in 12 mo
TTesi6 companies · 3 deals in 12 mo
TThe FSE Group6 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.
Share is of the 4 rounds on Recent Funding that name Advent Life Sciences. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Advent Life Sciences, which is a subset of its real portfolio. API: /api/v1/investors/advent-life-sciences (get a free API key). More: the most active VC firms and new venture capital funds.